Perspectives for Induced Pluripotent Stem Cell Technology-Reference-Cited by-同舟云学术

Perspectives for Induced Pluripotent Stem Cell Technology

Published:2014-01-31 Issue:3 Volume:114 Page:505-510
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circ Res

Author:

Nagata Naoki¹,Yamanaka Shinya¹

Affiliation:

1. From the Department of Reprogramming Science, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan (N.N., S.Y.); and Gladstone Institute of Cardiovascular Disease, San Francisco, CA (S.Y.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference67 articles.

1. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors

2. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

3. Directly Reprogrammed Fibroblasts Show Global Epigenetic Remodeling and Widespread Tissue Contribution

4. Generation of germline-competent induced pluripotent stem cells

5. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell models for Alzheimer’s and Parkinson’s disease: At the interface of biology and drug discovery;Biomedicine & Pharmacotherapy;2022-05

2. Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytes;Scientific Reports;2019-09-12

3. Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives;Scientific Data;2017-03-28

4. Recent Developments in Stem and Progenitor Cell Therapy for Cardiac Repair;Circulation Research;2016-12-09

5. Ultra-fast local-haplotype variant calling using paired-end DNA-sequencing data reveals somatic mosaicism in tumor and normal blood samples;Nucleic Acids Research;2015-09-29